<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004818'>Paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) is an acquired clonal disease of hematopoiesis due to a mutation in the PIG-A gene </plain></SENT>
<SENT sid="1" pm="."><plain>Affected patients may demonstrate <z:mp ids='MP_0010163'>hemolysis</z:mp> or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and may develop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Successful results may be obtained after conditioning and transplantation from syngeneic or genotypically matched sibling donors </plain></SENT>
<SENT sid="3" pm="."><plain>Experience with transplantation from matched unrelated donors (MUD) is limited to eight patients, with only one survivor </plain></SENT>
<SENT sid="4" pm="."><plain>We report three patients who underwent successful MUD BMT for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three patients had severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> at the time of BMT </plain></SENT>
<SENT sid="6" pm="."><plain>Unrelated donors were six-antigen HLA-matched (n = 2) or HLA-A mismatched (n = 1) </plain></SENT>
<SENT sid="7" pm="."><plain>Conditioning consisted of <z:chebi fb="0" ids="28680">cytarabine</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, TBI, and ATG </plain></SENT>
<SENT sid="8" pm="."><plain>Grafts were T cell-depleted by anti-CD6/CD8 antibodies + complement </plain></SENT>
<SENT sid="9" pm="."><plain>Further GVHD prophylaxis consisted of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Patients received 0.7-1.1 x 10(8) nucleated cells/kg and 1.1-2.1 x 10(6) CD34(+) cells/kg </plain></SENT>
<SENT sid="11" pm="."><plain>Neutrophil engraftment occurred at 16-21 days </plain></SENT>
<SENT sid="12" pm="."><plain>One patient developed grade 1 <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD </plain></SENT>
<SENT sid="13" pm="."><plain>Although <z:hpo ids='HP_0000001'>all</z:hpo> three patients experienced significant transplant-related complications, they ultimately resolved and <z:hpo ids='HP_0000001'>all</z:hpo> patients are alive and well 30-62 months after BMT </plain></SENT>
<SENT sid="14" pm="."><plain>T cell-depleted MUD BMT is an effective treatment option for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and SAA </plain></SENT>
</text></document>